eli lilly phase 3 trial retatrutide stock jumps on weight loss results Eli Lilly Experimental Drug Shows

Skin and hair claims vary widely in evidence quality

Physical Changes Beyond Weight Pay attention to changes in your body beyond just weight

And the SYNERGY program targets metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease

You may be a strong candidate for Epithalon therapy if you: Are interested in longevity and proactive aging support Experience fatigue, immune decline, or disrupted sleep Want to enhance cognitive clarity, stamina, or recovery Are seeking a science-backed anti-aging therapy without hormones or invasive procedures Want to support long-term cellular health and disease prevention Epithalon is often combined with other longevity-enhancing therapies such as CJC-1295 , NAD+ , and IV nutrient support for a comprehensive wellness strategy